Jean-François Lévesque
Department of Medicinal Chemistry
Merck Frosst Canada Ltd
16711 Transcanada Hwy.
Kirkland
Name/email consistency: high
- Metabolic activation of indole-containing prostaglandin D2 receptor 1 antagonists: impacts of glutathione trapping and glucuronide conjugation on covalent binding. Lévesque, J.F., Day, S.H., Chauret, N., Seto, C., Trimble, L., Bateman, K.P., Silva, J.M., Berthelette, C., Lachance, N., Boyd, M., Li, L., Sturino, C.F., Wang, Z., Zamboni, R., Young, R.N., Nicoll-Griffith, D.A. Bioorg. Med. Chem. Lett. (2007)
- Discovery, biosynthesis, and structure elucidation of new metabolites of norandrostenedione using in vitro systems. Lévesque, J.F., Gaudreault, M., Aubin, Y., Chauret, N. Steroids (2005)
- Discovery, biosynthesis, and structure elucidation of metabolites of a doping agent and a direct analogue, tetrahydrogestrinone and gestrinone, using human hepatocytes. Lévesque, J.F., Templeton, E., Trimble, L., Berthelette, C., Chauret, N. Anal. Chem. (2005)
- Evaluation of human hepatocyte incubation as a new tool for metabolism study of androstenedione and norandrostenedione in a doping control perspective. Lévesque, J.F., Gaudreault, M., Houle, R., Chauret, N. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2002)
